TGF-β plays a critical role in tumorigenesis and promotes CRC development by stimulating epithelial-to-mesenchymal transition [36], suggesting that GSK137647 may inhibit CRC progression. The gene discussed is TGFB1; the disease is colorectal carcinoma.